Articles | EuroIntervention

EXPERT REVIEW

10.4244/EIJ-D-17_00487 • Sep 24, 2017

Transcatheter tricuspid valve intervention: state of the art

Taramasso M, Maisano F

free

EXPERT REVIEW

10.4244/EIJ-D-17-00571 • Sep 24, 2017

The big parade: emerging percutaneous mitral and tricuspid valve devices

Natarajan D, Joseph J, Denti P, Redwood S, Prendergast B

free

EXPERT REVIEW

10.4244/EIJ-D-17-00501 • Sep 24, 2017

Percutaneous pulmonary valve implantation: what have we learned over the years?

Boudjemline Y

free

10.4244/EIJ-D-17-00509 • Sep 24, 2017

Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration

Serruys PW, Miyazaki Y, Katsikis A, Abdelghani M, Leon MB, Virmani R, Carrel T, Cox M, Onuma Y, Soliman O

free

EXPERT REVIEW

10.4244/EIJ-D-17-00412 • Sep 24, 2017

Left atrial appendage occlusion

Nietlispach F, Moarof I, Taramasso M, Maisano F, Meier B

free

EXPERT REVIEW

10.4244/EIJ-D-17-00516 • Sep 24, 2017

Imaging for structural heart procedures: focus on computed tomography

Mooney J, Sellers SL, Ohana M, Cavalcante JL, Arepalli C, Grover R, Kim U, Selvakumar K, Blanke P, Leipsic J

free

10.4244/EIJV13I7A112 • Sep 20, 2017

Oral antithrombotic therapy after acute coronary syndromes: “dual antiplatelet” or “dual pathway”?

Capodanno D

free

10.4244/EIJV13I7A113 • Sep 20, 2017

Two sides to every story: the trade-off between paravalvular leakage and the occurrence of conduction disturbances in transcatheter heart valves

Sinning J, Grube E

free

10.4244/EIJV13I7A114 • Sep 20, 2017

Do the results of the SYNTAX trial apply to my centre?

Le May M, Wells G, Chong A-Y

free

10.4244/EIJV13I7A115 • Sep 20, 2017

Bioresorbable scaffolds: reflections after a setback - losing a battle does not mean losing the war!

Colombo A, Azzalini L

free

• Sep 20, 2017

Focus on the two types of EAPCI fellowships: the one-year fellowship and the μFellowship.

free

CLINICAL RESEARCH

10.4244/EIJ-D-16-01024 • Sep 20, 2017

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Feldman T, Allocco DJ, Dawkins K

free

CLINICAL RESEARCH

10.4244/EIJ-D-16-01025 • Sep 20, 2017

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Houle V, Allocco DJ, Dawkins K

free

CLINICAL RESEARCH

10.4244/EIJ-D-16-00927 • Sep 20, 2017

Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement

Gutmann A, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Bothe W, von zur Mühlen C, Zehender M, Reinöhl J, Bode C, Stachon P

free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00094 • Sep 20, 2017

Effect of reduced cardiac output on blood stasis on transcatheter aortic valve leaflets: implications for valve thrombosis

Vahidkhah K, Abbasi M, Barakat M, Azadani P, Tandar A, Dvir D, Azadani A

free